Planning Capital Management Corporation’s Zomedica Corp. ZOM Stock Holding History

Planning Capital Management Corporation’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$220	Buy	+1,600	New	+$224	﹤0.01%	696

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Planning Capital Management Corporation's ZOM Position: Q3 2024 in Review

Planning Capital Management Corporation opened a new position in Zomedica Corp. (ZOM) in Q3 2024: 1,600 shares worth $220. The stake represents ﹤0.01% of the portfolio and ranks #696 among its holdings.

84 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

Planning Capital Management Corporation held 1,600 shares of Zomedica Corp. worth $220 as of Q3 2024.
Zomedica Corp. was a new Planning Capital Management Corporation position in Q3 2024.
Zomedica Corp. made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #696 holding.
84 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.